1Hz Arm for Gastroparesis

Augusta University, Augusta, GA
Gastroparesis2400 ThorS-MagNT Stimulations at 10Hz - Device
18 - 85
All Sexes
What conditions do you have?

Study Summary

This trial is testing a new noninvasive treatment for gastroparesis that uses neuromodulation to improve symptoms. The hypothesis is that this new treatment will be better than a sham treatment at improving symptoms.

Eligible Conditions
  • Diabetic Gastroparesis

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 4 weeks

4 weeks
Quality of life (QOL)
Responder rate

Trial Safety

Phase-Based Safety

1 of 3

Trial Design

3 Treatment Groups

1Hz Arm
1 of 3
10Hz Arm
1 of 3
Sham Arm
1 of 3

Active Control

Non-Treatment Group

48 Total Participants · 3 Treatment Groups

Primary Treatment: 1Hz Arm · Has Placebo Group · N/A

1Hz Arm
ActiveComparator Group · 1 Intervention: 2400 ThorS-MagNT Stimulations at 1Hz · Intervention Types: Device
Sham Arm
ShamComparator Group · 1 Intervention: Sham Stimulations · Intervention Types: Device
10Hz Arm
ActiveComparator Group · 1 Intervention: 2400 ThorS-MagNT Stimulations at 10Hz · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 4 weeks

Who is running the clinical trial?

Augusta UniversityLead Sponsor
196 Previous Clinical Trials
74,099 Total Patients Enrolled
1 Trials studying Gastroparesis
12 Patients Enrolled for Gastroparesis

Eligibility Criteria

Age 18 - 85 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You do not have any known diseases affecting the lining of your body's internal organs.

Who else is applying?

What state do they live in?
How old are they?
What site did they apply to?
Augusta University100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%

Frequently Asked Questions

Am I eligible to take part in this research initiative?

"This study has 48 places for outpatients, aged 18-85, with gastroparesis and refractory symptoms. Other criteria include: no known mucosal diseases; fluency in English (as self-reported); and having been on a consistent dose of any medications (excluding psychotropic drugs or opioids) within the previous 30 days - without changes during the trial duration." - Anonymous Online Contributor

Unverified Answer

To what extent is participation in this research opportunity being limited?

"Affirmative. According to clinicaltrials.gov, the research is open for enrollment and has been since its initial posting on June 27th 2022; it was last edited two days later on June 29th. Currently, 48 patients are required across a single site." - Anonymous Online Contributor

Unverified Answer

Is this research presently open to enrollment?

"Indeed, the current information hosted on clinicaltrials.gov reveals that recruitment for this medical trial is still ongoing; the study was initially posted on June 27th 2022 and last updated two days later. This research requires 48 individuals from 1 location to take part in it." - Anonymous Online Contributor

Unverified Answer

Does this experiment have any age restrictions for participating participants?

"This medical experiment has strict age criteria with a lower limit of 18 years old and an upper bound of 85." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.